Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd W Scheithauer

Showing results (261-270 of 266) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 266 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Pituitary|July 12, 2011
Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutationLuis V Syro, Jamie L Sundsbak, Bernd W Scheithauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumorJinsheng Yu, Hrishikesh Deshmukh, Jacqueline E Payton, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphomaNadia N Laack, Brian Patrick O'Neill, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
The Lancet. Neurology|July 10, 2003
Global democratic consensus on neuropathological disease criteriaCristian Achim, Roland Auer, Catherine Bergeron, et al.
Pageof 27

Showing results (261-270 of 266) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 266 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Pituitary|July 12, 2011
Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutationLuis V Syro, Jamie L Sundsbak, Bernd W Scheithauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumorJinsheng Yu, Hrishikesh Deshmukh, Jacqueline E Payton, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphomaNadia N Laack, Brian Patrick O'Neill, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
The Lancet. Neurology|July 10, 2003
Global democratic consensus on neuropathological disease criteriaCristian Achim, Roland Auer, Catherine Bergeron, et al.
Pageof 27